Dynamic Gait Index in Children With Dyslexia

January 21, 2023 updated by: Marmara University

Reliability of the Dynamic Gait Index in Children With Dyslexia

The aim of the present study is to investigate reliability in dyslexic children and compare it with healthy peers.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Assessments methods are very important for the detection and treatment of such problems and there is a need for studies that can be applied for the dyslexia group. However fewer attempts have been made to demonstrate the reliability of balance impairments tools in dyslexic children. The DGI is a test that has been used a lot lately because of its minimal requirement for space and equipment, as well as its ability to be used with different patients' groups. The aim of the present study is to investigate reliability in dyslexic children and compare it with healthy peers.

Study Type

Observational

Enrollment (Actual)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Istanbul, Turkey, 34890
        • Marmara University School of Medicine Department of Physical Medicine and Rehabilitation

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

8 years to 14 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

30 dyslexia patients, between 8 - 14 years of age, and 30 healthy volunteer peers

Description

Inclusion Criteria:

  • Confirmed diagnosis of dyslexia by Child and Adolescent Psychiatry
  • Intelligence quotient (IQ)> 85 results of WISC-R
  • Age between 8 - 14
  • Able to understand the commands given
  • Volunteer to study

Exclusion Criteria:

  • Having cognitive disorder
  • Having neuromuscular disorder
  • Having skeletal anomaly
  • Having visual or hearing problems

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Dyslexia Group
30 patients will be included. Dynamic Gait Index and other assessments will be performed twice with a 7-day interval by two evaluators
Other: Dynamic Gait Index
The Dynamic Gait Index (DGI) measures functionality and dynamic balance in walking and stair climbing. The DGI consists of 8 items including normal gait on flat ground, gait with speed changes, gait with horizontal head movements, gait with vertical head movements, gait and pivot turn, gait and step over an obstacle, gait around obstacles and steps up and downstairs. The performance on each item is rated on a 4-point scale ranging from 0 (severe disorder) to 3 (independent walking). The total score is 24.
Healthy Control Group
30 healthy children will be included. Dynamic Gait Index will be performed.
Other: Dynamic Gait Index
The Dynamic Gait Index (DGI) measures functionality and dynamic balance in walking and stair climbing. The DGI consists of 8 items including normal gait on flat ground, gait with speed changes, gait with horizontal head movements, gait with vertical head movements, gait and pivot turn, gait and step over an obstacle, gait around obstacles and steps up and downstairs. The performance on each item is rated on a 4-point scale ranging from 0 (severe disorder) to 3 (independent walking). The total score is 24.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Dynamic Gait Index
Time Frame: Day 0
The Dynamic Gait Index measures functionality and dynamic balance in walking and stair climbing. The DGI consists of 8 items including normal gait on flat ground, gait with speed changes, gait with horizontal head movements, gait with vertical head movements, gait and pivot turn, gait and step over obstacle, gait around obstacles and steps up and down stairs. The performance on each item is rated on a 4-point scale ranging from 0 (severe disorder) to 3 (independent walking). The total score is 24.
Day 0
The Dynamic Gait Index
Time Frame: Day 3
The Dynamic Gait Index measures functionality and dynamic balance in walking and stair climbing. The DGI consists of 8 items including normal gait on flat ground, gait with speed changes, gait with horizontal head movements, gait with vertical head movements, gait and pivot turn, gait and step over obstacle, gait around obstacles and steps up and down stairs. The performance on each item is rated on a 4-point scale ranging from 0 (severe disorder) to 3 (independent walking). The total score is 24.
Day 3

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Timed Up and Go Test
Time Frame: Day 0
The Timed Up and Go is a test used to measure mobility and evaluates walking speed, posture control, functional mobility and balance.
Day 0
Functional Reach Test
Time Frame: Day 0
Functional Reach Test (FRT) is a static balance test. Measurement is carried out by a tape measure attached to the wall parallel to the floor. The individual was standing parallel to a wall with the feet shoulder wide apart and the shoulders extended at 90 degrees flexion; in this position the third metacarpal head was recorded as the initial position. Then, the patient was asked to reach as forward as (s)he can, without taking a step. Again, the evaluator determined the position of the third metacarpal. The difference in centimeters between the first and second marks determined the FRT value. The FRT was performed three times and average value was taken.
Day 0

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Marmara University

Investigators

  • Study Chair: Naime Evrim Karadag-Saygi, Prof, Department of PM&R, Marmara University School of Medicine

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 2, 2018

Primary Completion (Actual)

June 1, 2018

Study Completion (Actual)

July 31, 2018

Study Registration Dates

First Submitted

January 16, 2020

First Submitted That Met QC Criteria

January 16, 2020

First Posted (Actual)

January 22, 2020

Study Record Updates

Last Update Posted (Estimate)

January 24, 2023

Last Update Submitted That Met QC Criteria

January 21, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 02.04.2018 - 112

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dyslexia

Clinical Trials on Dynamic Gait Index

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Singapore

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe